Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hanchuan Zupa Granules for post-common-cold cough in children (phase II/III seamless design)
CTR20233915Phase 3Active
- Sponsor
- Xinqikang Pharmaceutical
- Start
- Dec 2023
- Countries
- 1
01
Overview
A Phase 3 trial of Hanchuan Zupa Granule in postinfectious cough, upper respiratory infection (URI), sponsored by Xinqikang Pharmaceutical. Started Dec 2023; status: active.
02
Drugs
Hanchuan Zupa Granule
03
Conditions
postinfectious coughupper respiratory infection (URI)
Beyond the preview
Go deeper on CTR20233915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233915.